RH Capital is an impact venture capital fund that invests in early-stage startups focused on women's health, aiming to revolutionize care and improve health equity in the US. Their strategy prioritizes transformative innovation, access for underserved communities, affordability, and systemic change, with primary focus areas including contraception and maternal health.
100% of their portfolio is in Healthcare. Their most common stage is series-a (80% of deals). Average disclosed round size is $9.4M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$43.5M
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Twentyeight Health | Series A | $10M | Jan 2025 |
 Raydiant Oximetry, Inc. | Series A | $7.5M | Jun 2024 |
 Evvy | Series A | $14M | Sep 2023 |
 Eli Health | Seed | $3.6M | Apr 2023 |
 Cayaba Care | Series A | $12M | Jun 2022 |
Top Co-Investors
Muse Capital1 shared
Kapor Capital1 shared
Left Lane Capital1 shared
General Catalyst1 shared
Labcorp1 shared
Ingeborg Investments1 shared
G9 Ventures1 shared
Virtue1 shared
Amboy Street Ventures1 shared
Impact America Fund1 shared
Impact Engine1 shared
Gratitude Railroad1 shared
Cross Border Impact Ventures1 shared
Last updated: 18 March 2026